查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629231

靜脈 (IV)水合治療市場，按成分、按應用、按最終用途、按國家和地區分類 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Intravenous (IV) Hydration Therapy Market, By Component, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024 年，靜脈 (IV)水合療法市場規模為 26.7825 億美元，2025 年至 2032 年複合年成長率為 8.1%。

靜脈（IV）水合治療市場-市場動態

脫水相關疾病盛行率上升推動市場成長

脫水相關疾病盛行率的上升是靜脈水化治療市場成長的重要驅動力。脫水可能由多種因素引起，包括過熱、疾病、營養不良或劇烈的體力活動，並可能導致嚴重的併發症，如腎衰竭、中暑和電解質失衡。隨著氣候變遷、氣溫上升和熱浪頻率增加等全球健康挑戰，脫水變得更加普遍，特別是在老年人、兒童和慢性病患者等弱勢群體中。除了環境因素外，胃腸炎、糖尿病和慢性腎臟病等疾病也會導致脫水率升高，進一步增加了對有效水合療法的需求。靜脈水化治療在緊急護理環境中至關重要，快速補充液體和電解質對於預防進一步的併發症至關重要。據世界衛生組織 (WHO) 稱，脫水每年導致 130 萬人死亡，其中很大一部分死亡發生在低收入和中等收入國家。人們對補液療法重要性的認知不斷提高，以及更先進的靜脈補液解決方案的出現，預計將推動市場的擴張。

靜脈 (IV)水合治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032 年）每年將以 8.1% 左右的複合年成長率成長
  • 根據組件細分，Mediated 預計將在 2024 年顯示最大的市場佔有率
  • 根據最終用途細分，醫院將成為 2024 年的主導職能
  • 按地區分類，北美是 2024 年的主要收入來源

靜脈 (IV)水合療法市場區隔分析：

全球靜脈 (IV)水合治療市場根據成分、應用、最終用途和地區進行細分。

市場依成分分為五類：藥物和非藥物。藥物因其能夠治療特定的醫療狀況（例如電解質失衡、感染和營養不良）並提供有針對性的治療益處而在市場上佔據主導地位。它們在重症監護環境中的有效性確保了醫療保健提供者的更高需求和偏好。

根據最終用途，市場分為三類：醫院、健康中心和水療中心以及家庭醫療保健。醫院因其在提供緊急護理和重症監護方面的核心作用而佔據市場主導地位，而快速補液對於患者的穩定至關重要。此外，醫院擁有有效實施專門水合治療的基礎設施和資源。

靜脈 (IV)水合治療市場 - 地理洞察

由於先進的醫療設施、對緊急和重症護理服務的高需求以及對靜脈水化療法益處的廣泛認知，北美佔據了主導佔有率。尤其是在美國，用於醫療和健康目的的靜脈補水的使用有所增加，包括用於管理中暑、流感和胃腸道問題等各種病症引起的脫水。德國和英國在醫療保健方面處於領先地位，越來越多的醫院採用靜脈水化療法來照顧病人。由於醫療保健系統的改善、城市化進程的加快以及慢性病患病率的上升，亞太地區，特別是印度和中國，正在經歷快速成長，導致對水合療法的需求更高。由於醫療保健服務的改善以及人們對靜脈補水在治療脫水中的作用的認知不斷提高，拉丁美洲和中東地區也出現了成長。

靜脈（IV）水合治療市場-競爭格局：

靜脈（IV）水化治療市場的競爭格局的特點是存在幾個關鍵參與者，從成熟的製藥公司到專門從事醫療保健解決方案的新興新創公司。公司專注於策略合作夥伴關係、合併、收購和合作，以增強其產品供應並擴大其市場範圍。除了大型製藥公司之外，靜脈輸液服務的專業提供者也越來越受歡迎，直接向消費者提供服務，特別是在健康和門診環境中。隨著人們出於非醫療目的（例如宿醉恢復或提高運動表現）尋求水合療法，這些服務越來越受到關注。此外，靜脈注射技術的進步，例如智慧型輸液幫浦和改進的液體配方，也有助於增強競爭動力。公司也投資研發，以針對特定醫療狀況打造更有效、更專業的補水解決方案，進一步加劇市場競爭。由於市場受到嚴格監管，特別是在醫療保健領域，監管批准和遵守行業標準對於公司保持競爭優勢至關重要。在不斷成長的醫療保健需求、不斷提高的意識和技術創新等因素的推動下，對靜脈水化療法的需求不斷成長，導致了競爭環境，企業必須創新並適應不斷變化的市場趨勢。

最新進展：

  • 2024 年 4 月，Evocus 推出了全新水合產品 Evocus 水合 IV，旨在透過其獨特的主動吸收技術提供快速的水平衡和增強的性能。這種電解質飲料混合物不含人工添加劑和咖啡因，針對尋求快速補水的個人，特別是那些生活方式活躍的人，包括運動員。它有多種口味可供選擇，被定位為促進水分和肌肉恢復的更健康替代品，重點是改善身心健康。
  • 2024 年7 月，ChromaDex 宣布計劃從8 月開始在領先的健康診所首次推出其醫藥級靜脈注射Niagen(R)（氯化煙醯胺核苷），為傳統NAD+ IV 療法提供更快、更有效的替代方案。這款新產品具有卓越的耐受性、更短的輸注時間和更高的 NAD+ 血液水平，使其成為不斷成長的靜脈補液市場中一項有前途的創新。
  • 2024 年 4 月，美國頂級粉狀補水品牌 Liquid IV 進軍澳洲市場，推出水合 Multiplier 來解決當地的補水挑戰。該產品非常注重健康，旨在比單純喝水更快地改善水分，含有必需的維生素和電解質，並將在當地生產以滿足不斷成長的需求。聯合利華於 2020 年收購 Liquid IV，推動了其國際成長，該產品現已在澳洲領先零售商處銷售。

目錄

第 1 章：靜脈 (IV)水合療法市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 靜脈 (IV)水合療法市場片段（按成分）
    • 靜脈 (IV)水合療法市場片段（按應用）
    • 按最終用途分類的靜脈 (IV)水合療法市場片段
    • 按國家/地區分類的靜脈 (IV)水合療法市場片段
    • 按地區分類的靜脈 (IV)水合療法市場片段
  • 競爭洞察

第 3 章：靜脈 (IV)水合療法主要市場趨勢

  • 靜脈 (IV)水合療法市場促進因素
    • 市場促進因素的影響分析
  • 靜脈 (IV)水合治療市場限制
    • 市場限制影響分析
  • 靜脈 (IV)水合治療市場機會
  • 靜脈（IV）水合治療市場未來趨勢

第 4 章：靜脈 (IV)水合療法產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：靜脈 (IV)水合治療市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：靜脈 (IV)水合治療市場格局

  • 2024 年靜脈 (IV)水合療法市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：靜脈 (IV)水合治療市場 - 按組成部分

  • 概述
    • 按組成部分分類的細分市場佔有率分析
    • 藥
    • 非藥物

第 8 章：靜脈 (IV)水合治療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 免疫增強劑
    • 能量助推器
    • 皮膚護理
    • 偏頭痛
    • 其他

第 9 章：靜脈 (IV)水合治療市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 健康中心和水療中心
    • 家庭醫療保健

第 10 章：靜脈 (IV)水合治療市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美靜脈 (IV)水合療法主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按組成部分）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲靜脈 (IV)水合療法主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按組成部分）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區靜脈 (IV)水合療法主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按組成部分）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲靜脈 (IV)水合療法主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按組成部分）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲靜脈 (IV)水合療法主要製造商
    • MEA 市場規模和預測（按國家/地區）
    • MEA 市場規模和預測（按組成部分）
    • MEA 市場規模和預測（按應用）
    • MEA 市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 靜脈 (IV)水合治療產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Baxter International
    • Fresenius Kabi
    • B. Braun Melsungen AG
    • Pfizer company
    • Otsuka Pharmaceutical
    • Terumo Corporation
    • Medline Industries
    • Sagent Pharmaceuticals
    • Amgen
    • Vifor Pharma
    • ICU Medical
    • Chugai Pharmaceutical
    • Cipla
    • Zhejiang Hisun Pharmaceutical
    • Viatris
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4560

REPORT HIGHLIGHT

Intravenous (IV) Hydration Therapy Market size was valued at US$ 2,678.25 Million in 2024, expanding at a CAGR of 8.1% from 2025 to 2032.

Intravenous (IV) hydration therapy involves the administration of fluids directly into a patient's bloodstream through an IV line. This method ensures rapid delivery of fluids, electrolytes, and nutrients, bypassing the digestive system for immediate absorption. IV hydration therapy is commonly used in medical settings to treat dehydration caused by conditions like vomiting, diarrhea, fever, or excessive heat exposure. It is also vital for patients recovering from surgery, illnesses, or those with chronic conditions that impair fluid absorption. The need for IV hydration therapy arises when the body cannot adequately absorb or retain fluids orally, or when rapid rehydration is necessary. It is crucial in situations where oral hydration is not effective or feasible, such as in cases of severe dehydration or electrolyte imbalances. By replenishing lost fluids and electrolytes, IV hydration helps restore normal body functions, ensuring proper circulation, temperature regulation, and nutrient transport. The importance of IV hydration therapy lies in its ability to stabilize critical patients quickly and efficiently. It prevents complications such as kidney failure, shock, and organ dysfunction that can arise from severe dehydration. Additionally, IV therapy supports recovery and enhances overall well-being, especially in emergency care, post-operative recovery, and intensive care units.

Intravenous (IV) Hydration Therapy Market- Market Dynamics

Rising Prevalence of dehydration-related conditions to drive the market growth

The rising prevalence of dehydration-related conditions is a significant driver for the growth of the IV hydration therapy market. Dehydration can result from various factors, including excessive heat, illness, malnutrition, or intense physical activity, and can lead to severe complications such as kidney failure, heat stroke, and electrolyte imbalances. With global health challenges like climate change, rising temperatures, and the increasing frequency of heatwaves, dehydration has become more common, particularly in vulnerable populations like the elderly, children, and those with chronic illnesses. In addition to environmental factors, conditions such as gastroenteritis, diabetes, and chronic kidney disease contribute to higher dehydration rates, further increasing the need for effective hydration therapies. IV hydration therapy is essential in emergency care settings, where rapid fluid and electrolyte replenishment are critical to preventing further complications. According to the World Health Organization (WHO), dehydration is responsible for 1.3 million deaths annually, with a large percentage of these deaths occurring in low- and middle-income countries. The growing awareness of the importance of rehydration therapies and the availability of more advanced IV hydration solutions are expected to drive the market's expansion.

Intravenous (IV) Hydration Therapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2025-2032)
  • Based on Component segmentation, Medicated was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Hospitals was the leading Function in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Intravenous (IV) Hydration Therapy Market- Segmentation Analysis:

The Global Intravenous (IV) Hydration Therapy Market is segmented on the basis of Component, Application, End-Use and Region.

The market is divided into five categories based on Component: Medicated and Non-Medicated. Medicated dominate the market due to their ability to treat specific medical conditions, such as electrolyte imbalances, infections, and malnutrition, offering targeted therapeutic benefits. Their effectiveness in critical care settings ensures higher demand and preference among healthcare providers.

The market is divided into three categories based on End-Use: Hospitals, Wellness Centres & Spas, and Home Healthcare. Hospitals dominate the market due to their central role in providing emergency and intensive care, where rapid rehydration is crucial for patient stabilization. Additionally, hospitals have the infrastructure and resources to administer specialized hydration treatments effectively.

Intravenous (IV) Hydration Therapy Market- Geographical Insights

North America holds a dominant share due to advanced healthcare facilities, high demand for emergency and critical care services, and widespread awareness about the benefits of IV hydration therapy. The U.S., in particular, has seen an increase in the use of IV hydration for medical and wellness purposes, including for managing dehydration from various conditions like heat stroke, flu, and gastrointestinal issues.In Europe, the market is growing steadily, with countries like Germany and the UK leading in healthcare advancements and a rising number of hospitals adopting IV hydration therapy for patient care. The Asia-Pacific region, particularly India and China, is experiencing rapid growth due to improving healthcare systems, rising urbanization, and an increasing prevalence of chronic diseases, leading to higher demand for hydration therapies. Latin America and the Middle East are also witnessing growth, driven by improvements in healthcare access and rising awareness of IV hydration's role in treating dehydration.

Intravenous (IV) Hydration Therapy Market- Competitive Landscape:

The competitive landscape of the intravenous (IV) hydration therapy market is characterized by the presence of several key players, ranging from established pharmaceutical companies to emerging startups specializing in healthcare solutions. Companies are focusing on strategic partnerships, mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach. In addition to large pharmaceutical firms, specialized providers of IV hydration services are gaining popularity, offering services directly to consumers, particularly in wellness and outpatient settings. These services are gaining traction as people seek hydration therapies for non-medical purposes, such as hangover recovery or athletic performance enhancement. Furthermore, advancements in IV infusion technologies, such as smart infusion pumps and improved fluid formulations, are contributing to the competitive dynamics. Companies are also investing in research and development to create more effective and specialized hydration solutions tailored to specific medical conditions, further fueling market competition. Regulatory approvals and compliance with industry standards are essential for companies to maintain a competitive edge, as the market is heavily regulated, particularly in healthcare settings. The increasing demand for IV hydration therapy, driven by factors like rising healthcare needs, growing awareness, and technological innovations, has resulted in a competitive environment where companies must innovate and adapt to evolving market trends.

Recent Developments:

  • In April 2024, Evocus launched its new hydration product, Evocus Hydration IV, designed to offer rapid water balance and enhanced performance with its unique Active Absorption Technology. This electrolyte drink mix, free from artificial additives and caffeine, is targeted at individuals seeking quick hydration, particularly those with active lifestyles, including athletes. Available in multiple flavors, it is positioned as a healthier alternative for boosting hydration and muscle recovery, with a focus on improving both physical and mental well-being.
  • In July 2024, ChromaDex announced plans to debut its pharmaceutical-grade intravenous Niagen(R) (nicotinamide riboside chloride) at leading wellness clinics starting in August, offering a faster, more effective alternative to traditional NAD+ IV therapies. The new product promises superior tolerability, a shorter infusion time, and a higher rise in NAD+ blood levels, making it a promising innovation in the growing intravenous hydration market.
  • In April 2024, Liquid I.V., the top powdered hydration brand in the U.S., expanded into the Australian market, offering its Hydration Multiplier to address local hydration challenges. With a strong focus on wellness, the product aims to improve hydration faster than water alone, featuring essential vitamins and electrolytes, and will be manufactured locally to meet growing demand. Unilever's acquisition of Liquid I.V. in 2020 has fueled its international growth, with the product now available in leading Australian retailers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Baxter International
  • Fresenius Kabi
  • B. Braun Melsungen AG
  • Pfizer company
  • Otsuka Pharmaceutical
  • Terumo Corporation
  • Medline Industries
  • Sagent Pharmaceuticals
  • Amgen
  • Vifor Pharma
  • ICU Medical
  • Chugai Pharmaceutical
  • Cipla
  • Zhejiang Hisun Pharmaceutical
  • Viatris
  • Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Medicated
  • Non-medicated

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Wellness Centres & Spas
  • Home Healthcare

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intravenous (IV) Hydration Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intravenous (IV) Hydration Therapy Market Snippet by Component
    • 2.1.2. Intravenous (IV) Hydration Therapy Market Snippet by Application
    • 2.1.3. Intravenous (IV) Hydration Therapy Market Snippet by End-Use
    • 2.1.4. Intravenous (IV) Hydration Therapy Market Snippet by Country
    • 2.1.5. Intravenous (IV) Hydration Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Intravenous (IV) Hydration Therapy Key Market Trends

  • 3.1. Intravenous (IV) Hydration Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intravenous (IV) Hydration Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intravenous (IV) Hydration Therapy Market Opportunities
  • 3.4. Intravenous (IV) Hydration Therapy Market Future Trends

4. Intravenous (IV) Hydration Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intravenous (IV) Hydration Therapy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Intravenous (IV) Hydration Therapy Market Landscape

  • 6.1. Intravenous (IV) Hydration Therapy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intravenous (IV) Hydration Therapy Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Medicated
    • 7.1.3. Non-medicated

8. Intravenous (IV) Hydration Therapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Immune Boosters
    • 8.1.3. Energy Boosters
    • 8.1.4. Skin Care
    • 8.1.5. Migraine
    • 8.1.6. Others

9. Intravenous (IV) Hydration Therapy Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Wellness Centres & Spas
    • 9.1.4. Home Healthcare

10. Intravenous (IV) Hydration Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intravenous (IV) Hydration Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intravenous (IV) Hydration Therapy Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Baxter International
    • 11.2.2. Fresenius Kabi
    • 11.2.3. B. Braun Melsungen AG
    • 11.2.4. Pfizer company
    • 11.2.5. Otsuka Pharmaceutical
    • 11.2.6. Terumo Corporation
    • 11.2.7. Medline Industries
    • 11.2.8. Sagent Pharmaceuticals
    • 11.2.9. Amgen
    • 11.2.10. Vifor Pharma
    • 11.2.11. ICU Medical
    • 11.2.12. Chugai Pharmaceutical
    • 11.2.13. Cipla
    • 11.2.14. Zhejiang Hisun Pharmaceutical
    • 11.2.15. Viatris
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us